• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单心室循环新型混合综合二期手术的计算机模拟与体外分析

In-Silico and In-Vitro Analysis of the Novel Hybrid Comprehensive Stage II Operation for Single Ventricle Circulation.

作者信息

Das Arka, Hameed Marwan, Prather Ray, Farias Michael, Divo Eduardo, Kassab Alain, Nykanen David, DeCampli William

机构信息

Department of Mechanical Engineering, Embry-Riddle Aeronautical University, Daytona Beach, FL 32114, USA.

Department of Mechanical Engineering, American University of Bahrain, Riffa 942, Bahrain.

出版信息

Bioengineering (Basel). 2023 Jan 19;10(2):135. doi: 10.3390/bioengineering10020135.

DOI:10.3390/bioengineering10020135
PMID:36829630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9952694/
Abstract

Single ventricle (SV) anomalies account for one-fourth of all congenital heart disease cases. The existing palliative treatment for this anomaly achieves a survival rate of only 50%. To reduce the trauma associated with surgical management, the hybrid comprehensive stage II (HCSII) operation was designed as an alternative for a select subset of SV patients with the adequate antegrade aortic flow. This study aims to provide better insight into the hemodynamics of HCSII patients utilizing a multiscale Computational Fluid Dynamics (CFD) model and a mock flow loop (MFL). Both 3D-0D loosely coupled CFD and MFL models have been tuned to match baseline hemodynamic parameters obtained from patient-specific catheterization data. The hemodynamic findings from clinical data closely match the in-vitro and in-silico measurements and show a strong correlation (r = 0.9). The geometrical modification applied to the models had little effect on the oxygen delivery. Similarly, the particle residence time study reveals that particles injected in the main pulmonary artery (MPA) have successfully ejected within one cardiac cycle, and no pathological flows were observed.

摘要

单心室(SV)异常占所有先天性心脏病病例的四分之一。针对这种异常的现有姑息治疗的生存率仅为50%。为了减少与手术管理相关的创伤,混合综合二期(HCSII)手术被设计为一种替代方案,用于一部分具有足够主动脉顺行血流的SV患者。本研究旨在利用多尺度计算流体动力学(CFD)模型和模拟血流回路(MFL),更好地了解HCSII患者的血流动力学。3D-0D松耦合CFD模型和MFL模型均已进行调整,以匹配从患者特异性导管插入术数据获得的基线血流动力学参数。临床数据的血流动力学结果与体外和计算机模拟测量结果密切匹配,并显示出很强的相关性(r = 0.9)。应用于模型的几何形状修改对氧输送影响很小。同样,颗粒停留时间研究表明,注入主肺动脉(MPA)的颗粒在一个心动周期内成功排出,未观察到病理性血流。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/8ff5167fdb39/bioengineering-10-00135-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/222d1cda7423/bioengineering-10-00135-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4462771b22bc/bioengineering-10-00135-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/03ccf0f00da2/bioengineering-10-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/2c587e862e40/bioengineering-10-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/a7d3518d47d1/bioengineering-10-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/327e812da1da/bioengineering-10-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/0ef61cc0bd06/bioengineering-10-00135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/03c204cee76c/bioengineering-10-00135-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/792bcf4b2f90/bioengineering-10-00135-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/375848dc713a/bioengineering-10-00135-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/815fa6028858/bioengineering-10-00135-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/05f43948d9fe/bioengineering-10-00135-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/147522d7815e/bioengineering-10-00135-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/209361e3a8bb/bioengineering-10-00135-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/8f57bf91226c/bioengineering-10-00135-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/eb6198562f55/bioengineering-10-00135-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/561383bd7e53/bioengineering-10-00135-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/52bc903986f6/bioengineering-10-00135-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/8d4548b4c7e9/bioengineering-10-00135-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/c2f2952fedf7/bioengineering-10-00135-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/5a0a832e2951/bioengineering-10-00135-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4204b4d5369d/bioengineering-10-00135-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4e3d2aad53d6/bioengineering-10-00135-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/1857ef9786bb/bioengineering-10-00135-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/85f541616170/bioengineering-10-00135-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4d515bb8b212/bioengineering-10-00135-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/5c9bb2270913/bioengineering-10-00135-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/3113d98a1162/bioengineering-10-00135-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/602597edbf4a/bioengineering-10-00135-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/010cdf1b6261/bioengineering-10-00135-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/8ff5167fdb39/bioengineering-10-00135-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/222d1cda7423/bioengineering-10-00135-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4462771b22bc/bioengineering-10-00135-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/03ccf0f00da2/bioengineering-10-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/2c587e862e40/bioengineering-10-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/a7d3518d47d1/bioengineering-10-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/327e812da1da/bioengineering-10-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/0ef61cc0bd06/bioengineering-10-00135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/03c204cee76c/bioengineering-10-00135-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/792bcf4b2f90/bioengineering-10-00135-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/375848dc713a/bioengineering-10-00135-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/815fa6028858/bioengineering-10-00135-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/05f43948d9fe/bioengineering-10-00135-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/147522d7815e/bioengineering-10-00135-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/209361e3a8bb/bioengineering-10-00135-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/8f57bf91226c/bioengineering-10-00135-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/eb6198562f55/bioengineering-10-00135-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/561383bd7e53/bioengineering-10-00135-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/52bc903986f6/bioengineering-10-00135-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/8d4548b4c7e9/bioengineering-10-00135-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/c2f2952fedf7/bioengineering-10-00135-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/5a0a832e2951/bioengineering-10-00135-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4204b4d5369d/bioengineering-10-00135-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4e3d2aad53d6/bioengineering-10-00135-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/1857ef9786bb/bioengineering-10-00135-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/85f541616170/bioengineering-10-00135-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/4d515bb8b212/bioengineering-10-00135-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/5c9bb2270913/bioengineering-10-00135-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/3113d98a1162/bioengineering-10-00135-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/602597edbf4a/bioengineering-10-00135-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/010cdf1b6261/bioengineering-10-00135-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907b/9952694/8ff5167fdb39/bioengineering-10-00135-g029.jpg

相似文献

1
In-Silico and In-Vitro Analysis of the Novel Hybrid Comprehensive Stage II Operation for Single Ventricle Circulation.单心室循环新型混合综合二期手术的计算机模拟与体外分析
Bioengineering (Basel). 2023 Jan 19;10(2):135. doi: 10.3390/bioengineering10020135.
2
Computational fluid dynamics investigation of the novel hybrid comprehensive stage II operation.新型混合综合二期手术的计算流体动力学研究
JTCVS Open. 2021 Apr 27;7:308-323. doi: 10.1016/j.xjon.2021.04.009. eCollection 2021 Sep.
3
Effects of pulmonary artery banding and retrograde aortic arch obstruction on the hybrid palliation of hypoplastic left heart syndrome.肺动脉环扎术和逆行主动脉弓阻塞对左心发育不全综合征杂交姑息治疗的影响。
J Thorac Cardiovasc Surg. 2013 Dec;146(6):1341-8. doi: 10.1016/j.jtcvs.2013.01.038. Epub 2013 Feb 20.
4
Use of mathematical modeling to compare and predict hemodynamic effects between hybrid and surgical Norwood palliations for hypoplastic left heart syndrome.运用数学模型比较和预测左心发育不良综合征的杂交与外科 Norwood 姑息术的血液动力学效果。
Circulation. 2011 Sep 13;124(11 Suppl):S204-10. doi: 10.1161/CIRCULATIONAHA.110.010769.
5
Interventional Planning for Endovascular Revision of a Lateral Tunnel Fontan: A Patient-Specific Computational Analysis.侧隧道Fontan术血管腔内翻修的介入规划:一项基于患者特异性的计算分析
Front Physiol. 2021 Aug 13;12:718254. doi: 10.3389/fphys.2021.718254. eCollection 2021.
6
Use of mathematic modeling to compare and predict hemodynamic effects of the modified Blalock-Taussig and right ventricle-pulmonary artery shunts for hypoplastic left heart syndrome.运用数学模型比较并预测改良布莱洛克 - 陶西格分流术和右心室 - 肺动脉分流术对左心发育不全综合征的血流动力学影响。
J Thorac Cardiovasc Surg. 2008 Aug;136(2):312-320.e2. doi: 10.1016/j.jtcvs.2007.04.078.
7
Patient-Specific Multi-Scale Model Analysis of Hemodynamics Following the Hybrid Norwood Procedure for Hypoplastic Left Heart Syndrome: Effects of Reverse Blalock-Taussig Shunt Diameter.左心发育不全综合征杂交诺伍德手术后血流动力学的患者特异性多尺度模型分析:改良布莱洛克-陶西格分流直径的影响
Cardiovasc Eng Technol. 2019 Mar;10(1):136-154. doi: 10.1007/s13239-018-00396-w. Epub 2018 Dec 4.
8
Pulmonary Hemodynamics Simulations Before Stage 2 Single Ventricle Surgery: Patient-Specific Parameter Identification and Clinical Data Assessment.二期单心室手术前的肺血流动力学模拟:特定患者参数识别与临床数据评估
Cardiovasc Eng Technol. 2015 Sep;6(3):268-80. doi: 10.1007/s13239-015-0212-3. Epub 2015 Jan 22.
9
Hybrid approach to the comprehensive stage II operation in a subset of single-ventricle variants.杂交方法在单心室变体亚组中的综合 II 期手术。
J Thorac Cardiovasc Surg. 2015 Apr;149(4):1095-100. doi: 10.1016/j.jtcvs.2014.11.081. Epub 2014 Dec 3.
10
Heart blood flow simulation: a perspective review.心脏血流模拟:综述
Biomed Eng Online. 2016 Aug 25;15(1):101. doi: 10.1186/s12938-016-0224-8.

本文引用的文献

1
Computational fluid dynamics investigation of the novel hybrid comprehensive stage II operation.新型混合综合二期手术的计算流体动力学研究
JTCVS Open. 2021 Apr 27;7:308-323. doi: 10.1016/j.xjon.2021.04.009. eCollection 2021 Sep.
2
Clinical update on the hybrid comprehensive stage II operation.杂交综合二期手术的临床进展
JTCVS Open. 2021 May 8;7:327-335. doi: 10.1016/j.xjon.2021.04.019. eCollection 2021 Sep.
3
Parametric investigation of an injection-jet self-powered Fontan circulation.注射射流自供能法乐氏四联症循环的参数研究。
Sci Rep. 2022 Feb 9;12(1):2161. doi: 10.1038/s41598-022-05985-3.
4
Hybrid Procedures. Opening Doors for Surgeon and Cardiologist Close Collaboration.杂交手术:为外科医生和心脏病专家紧密合作开启大门。
Front Pediatr. 2021 Jul 27;9:687909. doi: 10.3389/fped.2021.687909. eCollection 2021.
5
Patient-Specific Multi-Scale Model Analysis of Hemodynamics Following the Hybrid Norwood Procedure for Hypoplastic Left Heart Syndrome: Effects of Reverse Blalock-Taussig Shunt Diameter.左心发育不全综合征杂交诺伍德手术后血流动力学的患者特异性多尺度模型分析:改良布莱洛克-陶西格分流直径的影响
Cardiovasc Eng Technol. 2019 Mar;10(1):136-154. doi: 10.1007/s13239-018-00396-w. Epub 2018 Dec 4.
6
Computational Investigation of a Self-Powered Fontan Circulation.自驱动Fontan循环的计算研究
Cardiovasc Eng Technol. 2018 Jun;9(2):202-216. doi: 10.1007/s13239-018-0342-5. Epub 2018 Feb 20.
7
Understanding the Hybrid Stage I Approach for Hypoplastic Left Heart Syndrome.了解用于左心发育不全综合征的一期杂交手术方法。
Crit Care Nurse. 2016 Oct;36(5):48-55. doi: 10.4037/ccn2016894.
8
Survival and right ventricular performance for matched children after stage-1 Norwood: Modified Blalock-Taussig shunt versus right-ventricle-to-pulmonary-artery conduit.1期诺伍德手术后匹配儿童的生存情况及右心室功能:改良布莱洛克-陶西格分流术与右心室至肺动脉导管术的比较
J Thorac Cardiovasc Surg. 2015 Dec;150(6):1440-50, 1452.e1-8; discussion 1450-2. doi: 10.1016/j.jtcvs.2015.06.069. Epub 2015 Jul 2.
9
Hemodynamics in a Pediatric Ascending Aorta Using a Viscoelastic Pediatric Blood Model.使用粘弹性儿科血液模型对小儿升主动脉血流动力学的研究。
Ann Biomed Eng. 2016 Apr;44(4):1019-35. doi: 10.1007/s10439-015-1370-z. Epub 2015 Jul 10.
10
Hemodynamic effects of left pulmonary artery stenosis after superior cavopulmonary connection: a patient-specific multiscale modeling study.上腔静脉肺动脉连接术后左肺动脉狭窄的血流动力学效应:一项基于患者个体的多尺度建模研究
J Thorac Cardiovasc Surg. 2015 Mar;149(3):689-96.e1-3. doi: 10.1016/j.jtcvs.2014.12.040. Epub 2014 Dec 20.